Literature DB >> 19587666

Biomarker validation by targeted mass spectrometry.

Martin McIntosh1, Matthew Fitzgibbon.   

Abstract

Mesh:

Substances:

Year:  2009        PMID: 19587666     DOI: 10.1038/nbt0709-622

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  9 in total

1.  Contribution of protein fractionation to depth of analysis of the serum and plasma proteomes.

Authors:  Vitor Faca; Sharon J Pitteri; Lisa Newcomb; Veronika Glukhova; Doug Phanstiel; Alexei Krasnoselsky; Qing Zhang; Jason Struthers; Hong Wang; Jimmy Eng; Matt Fitzgibbon; Martin McIntosh; Samir Hanash
Journal:  J Proteome Res       Date:  2007-08-16       Impact factor: 4.466

2.  Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma.

Authors:  Terri A Addona; Susan E Abbatiello; Birgit Schilling; Steven J Skates; D R Mani; David M Bunk; Clifford H Spiegelman; Lisa J Zimmerman; Amy-Joan L Ham; Hasmik Keshishian; Steven C Hall; Simon Allen; Ronald K Blackman; Christoph H Borchers; Charles Buck; Helene L Cardasis; Michael P Cusack; Nathan G Dodder; Bradford W Gibson; Jason M Held; Tara Hiltke; Angela Jackson; Eric B Johansen; Christopher R Kinsinger; Jing Li; Mehdi Mesri; Thomas A Neubert; Richard K Niles; Trenton C Pulsipher; David Ransohoff; Henry Rodriguez; Paul A Rudnick; Derek Smith; David L Tabb; Tony J Tegeler; Asokan M Variyath; Lorenzo J Vega-Montoto; Asa Wahlander; Sofia Waldemarson; Mu Wang; Jeffrey R Whiteaker; Lei Zhao; N Leigh Anderson; Susan J Fisher; Daniel C Liebler; Amanda G Paulovich; Fred E Regnier; Paul Tempst; Steven A Carr
Journal:  Nat Biotechnol       Date:  2009-06-28       Impact factor: 54.908

Review 3.  Challenges to cancer control by screening.

Authors:  Michael N Pollak; William D Foulkes
Journal:  Nat Rev Cancer       Date:  2003-04       Impact factor: 60.716

4.  Ovarian cancer tumor marker behavior in asymptomatic healthy women: implications for screening.

Authors:  C Crump; M W McIntosh; N Urban; G Anderson; B Y Karlan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2000-10       Impact factor: 4.254

5.  Head-to-head comparison of serum fractionation techniques.

Authors:  Jeffrey R Whiteaker; Heidi Zhang; Jimmy K Eng; Ruihua Fang; Brian D Piening; Li-Chia Feng; Travis D Lorentzen; Regine M Schoenherr; John F Keane; Ted Holzman; Matthew Fitzgibbon; ChenWei Lin; Hui Zhang; Kelly Cooke; Tao Liu; David G Camp; Leigh Anderson; Julian Watts; Richard D Smith; Martin W McIntosh; Amanda G Paulovich
Journal:  J Proteome Res       Date:  2007-02       Impact factor: 4.466

6.  Screening and prostate-cancer mortality in a randomized European study.

Authors:  Fritz H Schröder; Jonas Hugosson; Monique J Roobol; Teuvo L J Tammela; Stefano Ciatto; Vera Nelen; Maciej Kwiatkowski; Marcos Lujan; Hans Lilja; Marco Zappa; Louis J Denis; Franz Recker; Antonio Berenguer; Liisa Määttänen; Chris H Bangma; Gunnar Aus; Arnauld Villers; Xavier Rebillard; Theodorus van der Kwast; Bert G Blijenberg; Sue M Moss; Harry J de Koning; Anssi Auvinen
Journal:  N Engl J Med       Date:  2009-03-18       Impact factor: 91.245

7.  Mortality results from a randomized prostate-cancer screening trial.

Authors:  Gerald L Andriole; E David Crawford; Robert L Grubb; Saundra S Buys; David Chia; Timothy R Church; Mona N Fouad; Edward P Gelmann; Paul A Kvale; Douglas J Reding; Joel L Weissfeld; Lance A Yokochi; Barbara O'Brien; Jonathan D Clapp; Joshua M Rathmell; Thomas L Riley; Richard B Hayes; Barnett S Kramer; Grant Izmirlian; Anthony B Miller; Paul F Pinsky; Philip C Prorok; John K Gohagan; Christine D Berg
Journal:  N Engl J Med       Date:  2009-03-18       Impact factor: 91.245

8.  A HUPO test sample study reveals common problems in mass spectrometry-based proteomics.

Authors:  Alexander W Bell; Eric W Deutsch; Catherine E Au; Robert E Kearney; Ron Beavis; Salvatore Sechi; Tommy Nilsson; John J M Bergeron
Journal:  Nat Methods       Date:  2009-06       Impact factor: 28.547

9.  Systematic evaluation of candidate blood markers for detecting ovarian cancer.

Authors:  Chana Palmer; Xiaobo Duan; Sarah Hawley; Nathalie Scholler; Jason D Thorpe; Rob A Sahota; May Q Wong; Andrew Wray; Lindsay A Bergan; Charles W Drescher; Martin W McIntosh; Patrick O Brown; Brad H Nelson; Nicole Urban
Journal:  PLoS One       Date:  2008-07-09       Impact factor: 3.240

  9 in total
  3 in total

1.  Proteomics retrenches.

Authors:  Peter Mitchell
Journal:  Nat Biotechnol       Date:  2010-07       Impact factor: 54.908

2.  Highly Reproducible Automated Proteomics Sample Preparation Workflow for Quantitative Mass Spectrometry.

Authors:  Qin Fu; Michael P Kowalski; Mitra Mastali; Sarah J Parker; Kimia Sobhani; Irene van den Broek; Christie L Hunter; Jennifer E Van Eyk
Journal:  J Proteome Res       Date:  2017-11-10       Impact factor: 4.466

3.  iTRAQ-based quantitative analysis of age-specific variations in salivary proteome of caries-susceptible individuals.

Authors:  Kun Wang; Xiuqing Wang; Sainan Zheng; Yumei Niu; Wenyue Zheng; Xi Qin; Zhongcheng Li; Junyuan Luo; Wentao Jiang; Xuedong Zhou; Wei Li; Linglin Zhang
Journal:  J Transl Med       Date:  2018-10-25       Impact factor: 5.531

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.